196 related articles for article (PubMed ID: 36529908)
1. New Explainable Deep CNN Design for Classifying Breast Tumor Response Over Neoadjuvant Chemotherapy.
Adoui ME; Drisis S; Benjelloun M
Curr Med Imaging; 2022; 19(5):526-533. PubMed ID: 36529908
[TBL] [Abstract][Full Text] [Related]
2. Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images.
El Adoui M; Drisis S; Benjelloun M
Int J Comput Assist Radiol Surg; 2020 Sep; 15(9):1491-1500. PubMed ID: 32556920
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method.
Qu YH; Zhu HT; Cao K; Li XT; Ye M; Sun YS
Thorac Cancer; 2020 Mar; 11(3):651-658. PubMed ID: 31944571
[TBL] [Abstract][Full Text] [Related]
4. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
Fan M; Wu G; Cheng H; Zhang J; Shao G; Li L
Eur J Radiol; 2017 Sep; 94():140-147. PubMed ID: 28712700
[TBL] [Abstract][Full Text] [Related]
5. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
Wu J; Gong G; Cui Y; Li R
J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
[TBL] [Abstract][Full Text] [Related]
6. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
7. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using radiomics of pretreatment dynamic contrast-enhanced MRI.
Yoshida K; Kawashima H; Kannon T; Tajima A; Ohno N; Terada K; Takamatsu A; Adachi H; Ohno M; Miyati T; Ishikawa S; Ikeda H; Gabata T
Magn Reson Imaging; 2022 Oct; 92():19-25. PubMed ID: 35636571
[TBL] [Abstract][Full Text] [Related]
8. Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer.
Li Y; Fan Y; Xu D; Li Y; Zhong Z; Pan H; Huang B; Xie X; Yang Y; Liu B
Front Oncol; 2022; 12():1041142. PubMed ID: 36686755
[TBL] [Abstract][Full Text] [Related]
9. Prior to Initiation of Chemotherapy, Can We Predict Breast Tumor Response? Deep Learning Convolutional Neural Networks Approach Using a Breast MRI Tumor Dataset.
Ha R; Chin C; Karcich J; Liu MZ; Chang P; Mutasa S; Pascual Van Sant E; Wynn RT; Connolly E; Jambawalikar S
J Digit Imaging; 2019 Oct; 32(5):693-701. PubMed ID: 30361936
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging.
Han X; Yang H; Jin S; Sun Y; Zhang H; Shan M; Cheng W
Cancer Med; 2023 Jan; 12(2):1389-1398. PubMed ID: 35822639
[TBL] [Abstract][Full Text] [Related]
11. Explainable 3D CNN based on baseline breast DCE-MRI to give an early prediction of pathological complete response to neoadjuvant chemotherapy.
Comes MC; Fanizzi A; Bove S; Didonna V; Diotiaiuti S; Fadda F; La Forgia D; Giotta F; Latorre A; Nardone A; Palmiotti G; Ressa CM; Rinaldi L; Rizzo A; Talienti T; Tamborra P; Zito A; Lorusso V; Massafra R
Comput Biol Med; 2024 Apr; 172():108132. PubMed ID: 38508058
[TBL] [Abstract][Full Text] [Related]
12. Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patients.
Dammu H; Ren T; Duong TQ
PLoS One; 2023; 18(1):e0280148. PubMed ID: 36607982
[TBL] [Abstract][Full Text] [Related]
13. Deep Learning-Based Segmentation of Locally Advanced Breast Cancer on MRI in Relation to Residual Cancer Burden: A Multi-Institutional Cohort Study.
Janse MHA; Janssen LM; van der Velden BHM; Moman MR; Wolters-van der Ben EJM; Kock MCJM; Viergever MA; van Diest PJ; Gilhuijs KGA
J Magn Reson Imaging; 2023 Dec; 58(6):1739-1749. PubMed ID: 36928988
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment DCE-MRI-Based Deep Learning Outperforms Radiomics Analysis in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
Peng Y; Cheng Z; Gong C; Zheng C; Zhang X; Wu Z; Yang Y; Yang X; Zheng J; Shen J
Front Oncol; 2022; 12():846775. PubMed ID: 35359387
[TBL] [Abstract][Full Text] [Related]
15. Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.
Abramson RG; Li X; Hoyt TL; Su PF; Arlinghaus LR; Wilson KJ; Abramson VG; Chakravarthy AB; Yankeelov TE
Magn Reson Imaging; 2013 Nov; 31(9):1457-64. PubMed ID: 23954320
[TBL] [Abstract][Full Text] [Related]
16. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract][Full Text] [Related]
17. Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning.
Choi JH; Kim HA; Kim W; Lim I; Lee I; Byun BH; Noh WC; Seong MK; Lee SS; Kim BI; Choi CW; Lim SM; Woo SK
Sci Rep; 2020 Dec; 10(1):21149. PubMed ID: 33273490
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]